These results demonstrate superior performance compared to other GLP-1 agonists, insulin, and placebo [23, 24, 25, 26]
The Cochrane systematic review by Mulvaney et al
GLP-1 Receptor Activation The GLP-1 pathway is the foundation of modern weight loss therapies: Appetite Suppression : Acts on hypothalamic centers to reduce hunger signals Satiety Enhancement : Makes you feel fuller longer with smaller portions Gastric Motility : Slows stomach emptying, prolonging fullness Glucose Control : Stimulates insulin secretion and improves glucose homeostasis This is the mechanism behind semaglutide and tirzepatide's success, but retatrutide adds two additional pathways
These complaints are not universal, but they are consistent enough to warrant attention, particularly the subscription and cancellation issues
Founded on a mission to empower everyone everywhere to live better longer, Noom has received multiple National Institute of Health grants and was the first mobile app recognized by the CDC as a certified diabetes prevention program
